Jonathan McNeill
2023
In 2023, Jonathan McNeill earned a total compensation of $2.2M as Chief Business Officer at Dyne Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $230,880 |
|---|---|
| Option Awards | $522,287 |
| Salary | $430,468 |
| Stock Awards | $1,046,199 |
| Other | $996 |
| Total | $2,230,830 |
McNeill received $1M in stock awards, accounting for 47% of the total pay in 2023.
McNeill also received $230.9K in non-equity incentive plan, $522.3K in option awards, $430.5K in salary and $996 in other compensation.
Rankings
In 2023, Jonathan McNeill's compensation ranked 461st out of 2,983 executives tracked by ExecPay. In other words, McNeill earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 461 out of 2,983 | 85th |
Division Manufacturing | 265 out of 1,637 | 84th |
Major group Chemicals And Allied Products | 181 out of 906 | 80th |
Industry group Drugs | 178 out of 869 | 80th |
Industry Pharmaceutical Preparations | 111 out of 627 | 82nd |
Source: SEC filing on April 5, 2024.
McNeill's colleagues
We found two more compensation records of executives who worked with Jonathan McNeill at Dyne Therapeutics in 2023.